In 2013, the American Psychiatric Association released the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders. Buried in the revisions was a change that received remarkably little public attention: the removal of the bereavement exclusion for major depressive disorder. Before this change, clinicians were instructed not to diagnose depression in someone who had lost a loved one within the past two months, on the theory that grief is a normal human experience and should not be pathologized. After the change, grief could be coded as depression on day fifteen. The pharmaceutical industry applauded. Antidepressant prescriptions for the recently bereaved increased. The DSM had taken the most universal human experience -- loss -- and given it a billing code. This was not an isolated event. It was the culmination of a half-century trend that has quietly reshaped how we understand suffering, who profits from that understanding, and what gets lost when normal human pain is reclassified as dysfunction.

The Timeline Nobody Wants to Look At

The medicalization of emotional life has a remarkably clear history if you are willing to follow the money. In 1952, the first DSM listed 106 disorders. The DSM-5, published in 2013, listed nearly 300. This tripling did not occur because humans developed new forms of suffering. It occurred because the boundaries of what constitutes a disorder expanded -- consistently, across every revision, in directions that created new markets for pharmaceutical intervention. Sadness became depression. Shyness became social anxiety disorder. A child's inability to sit still for seven hours in a fluorescent room became ADHD. Grief became complicated grief disorder. The normal anxiety of existing in a world that provides abundant reasons for anxiety became generalized anxiety disorder. Each reclassification came with a diagnostic code, and each diagnostic code unlocked a prescription, and each prescription generated revenue. Research from the University of Massachusetts documented that 69% of DSM-5 task force members had financial ties to the pharmaceutical industry. This is not conspiracy. It is the published conflict-of-interest disclosures that the APA was required to release. The people deciding what constitutes a mental illness had direct financial relationships with the companies that sell treatments for mental illness.

My Grandmother Buried Her Son and Nobody Called It a Disorder

I need to tell you about my grandmother because the abstraction of this topic makes it easy to miss the human cost of getting it wrong in either direction. My uncle died in 1987. He was thirty-four. My grandmother was the kind of woman who could fillet a fish and quote Yeats and cry openly at the beauty of a well-made pie crust. After her son died, she went dark for about a year. She barely spoke. She wore the same cardigan every day. She sat in a chair by the window and looked at the yard and was not really there. Nobody diagnosed her. Nobody medicated her. Her sisters came and sat with her, wordlessly, for hours at a time. Her parish brought food. The neighbors mowed her lawn without asking. She moved through it the way humans have moved through unbearable loss for millennia -- slowly, surrounded, with the understanding that what was happening to her was not pathology but the correct response of a mammalian nervous system to the worst thing that can happen. By the second year, she was gardening again. By the third, she was herself -- not the same self, because the same self was no longer available, but a self that had integrated the loss rather than suppressed it. She carried my uncle with her for the remaining twenty-six years of her life. She talked about him freely. She cried about him freely. She was not "over it." She was through it, which is a different geography entirely. Under current diagnostic criteria, my grandmother would have met the threshold for major depressive disorder by week three. She would have been prescribed an SSRI. The grief that needed a year and a community would have been managed with a molecule and a forty-five-minute intake session. I am not anti-medication. Medication is sometimes the difference between life and death. But I am asking what happens to a society that reaches for a prescription before it asks whether the pain is a problem or a process.

Who Profits and Who Pays

Global antidepressant revenue exceeded $15 billion in 2023. The therapy industry -- apps, platforms, digital CBT programs -- added another $5 billion. Wellness, which is the monetization of the anxiety that the medical system creates and the pharmaceutical system does not fully resolve, is a $4.4 trillion global market. The pipeline works like this: define more experiences as disorders. Sell treatments for the disorders. When the treatments produce incomplete relief -- as they often do, because the original experience was not a disorder -- sell wellness products to address the residual suffering. Monetize every layer. Leave no pain unprofitable. Research from the University of Liverpool analyzed the effectiveness data for antidepressants and found that while they outperform placebo for severe depression, the clinical difference for mild to moderate depression -- which constitutes the majority of prescriptions -- was below the threshold of clinical significance. The drugs work for the people who need them most and produce marginal effects for the much larger population they are primarily prescribed to. We are mass-medicating normal human suffering and then wondering why the mental health crisis deepens. Maybe it deepens precisely because we have convinced 40 million Americans that their sadness is a chemical problem requiring a chemical solution, and when the chemical solution produces only partial relief, they conclude they are more broken than they thought.

The Thing We Lost When We Pathologized Everything

Here is the tangent that changed how I see this. There is a concept in ecology called a "controlled burn." Forest managers intentionally set fires to burn accumulated deadwood, because without periodic burns, the deadwood accumulates until an uncontrollable wildfire destroys everything. The small fires are not damage. They are maintenance. They are how the system stays healthy. Grief is a controlled burn. So is sadness. So is the anxiety that tells you something in your life is misaligned. So is the anger that signals a boundary has been crossed. These experiences are not comfortable. They are not pleasant. But they are functional. They are the emotional ecosystem doing maintenance work. When we pathologize the controlled burns, people stop letting them happen. They medicate the grief before it completes. They numb the anxiety before it delivers its message. They suppress the sadness before it clears the deadwood. And then they wonder why, years later, everything feels like an uncontrollable fire. A 2023 study from the University of Cambridge found that participants who were encouraged to sit with difficult emotions rather than immediately manage them showed greater emotional resilience six months later than those who used coping strategies to minimize distress. The sitting-with group was not happier in the short term. They were more durable in the long term. The pain was not the problem. The avoidance of pain was the problem.

What I Am Not Saying and What I Am

I am not saying therapy is bad. I am in therapy. I am not saying medication is unnecessary. For some people, it is lifesaving. I am not saying mental illness is not real. It is achingly, devastatingly real. What I am saying is that we have allowed the boundary between illness and normal suffering to be redrawn by institutions that profit from expanding the definition of illness. And the casualties are the people in the middle -- the millions who are sad but not sick, grieving but not disordered, anxious because the world is genuinely anxiety-producing and not because their brains are malfunctioning. Those people deserve something other than a diagnosis. They deserve a society that can tolerate their pain without immediately reaching for a label and a treatment plan. They deserve the controlled burn. They deserve the year in the chair by the window. They deserve the sisters who sit wordlessly, the neighbors who mow the lawn, the community that says: "This is hard and it will take a long time and you are not broken." Instead, we gave them an app. We gave them a diagnosis. We gave them a subscription. And then we called it care.